Your browser doesn't support javascript.
loading
A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma.
Di Meo, Francesco; Iyer, Anjushree; Akama, Keith; Cheng, Rujin; Yu, Christina; Cesarano, Annamaria; Kurihara, Noriyoshi; Tenshin, Hirofumi; Aljoufi, Arafat; Marino, Silvia; Soni, Rajesh K; Roda, Julie; Sissons, James; Vu, Ly P; Guzman, Monica; Huang, Kun; Laskowski, Tamara; Broxmeyer, Hal E; Roodman, David G; Perna, Fabiana.
Afiliação
  • Di Meo F; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Iyer A; NGM Biopharmaceuticals, San Francisco, CA, USA.
  • Akama K; NGM Biopharmaceuticals, San Francisco, CA, USA.
  • Cheng R; NGM Biopharmaceuticals, San Francisco, CA, USA.
  • Yu C; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Cesarano A; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Kurihara N; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Tenshin H; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Aljoufi A; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Marino S; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Soni RK; Proteomics and Macromolecular Crystallography Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Roda J; NGM Biopharmaceuticals, San Francisco, CA, USA.
  • Sissons J; NGM Biopharmaceuticals, San Francisco, CA, USA.
  • Vu LP; British Columbia Cancer Center, Vancouver, BC, Canada.
  • Guzman M; Weill Cornell Medical College, New York, NY, USA.
  • Huang K; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Laskowski T; Lonza Personalized Medicine, Basel, Switzerland.
  • Broxmeyer HE; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Roodman DG; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Perna F; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA; Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN
Cell Rep Med ; 4(7): 101110, 2023 07 18.
Article em En | MEDLINE | ID: mdl-37467717
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Animals Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Animals Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos